ARMP vs EMR · $70.2M cap vs P/E 34, rev $4.86B
Armata Pharmaceuticals Inc (ARMP) versus Emerson Electric Company (EMR) — a side-by-side from cached financials, not a winner call.
Armata Pharmaceuticals Inc (ARMP) is a biotechnology company listed on US.
Emerson Electric Company (EMR) is a specialty industrial machinery company listed on NYSE.
ARMP does not have a complete income-statement cache yet.
Latest reported EMR revenue for 2025-09-30 was $4.86B. Net income was $2.25B. Revenue was up 6.6% from 2025-06-30 to 2025-09-30. EMR currently screens at market cap $83.45B and trailing P/E 34.5.
ARMP currently screens at market cap $70.2M. EMR currently screens at market cap $83.45B and trailing P/E 34.5.
Not investment advice. Open the ARMP and EMR stock pages for the full models.
Not investment advice.